Cognitive effects of methylphenidate in healthy volunteers: A review of single dose studies

International Journal of Neuropsychopharmacology

Volumn 17, Issue 6, 2014, Pages 961-977

  Linssen, A M W ^a   Sambeth, A ^a   Vuurman, E F P M ^a   Riedel, W J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cognition; Dopamine; Memory; Methylphenidate

Indexed keywords

METHYLPHENIDATE; PLACEBO; CENTRAL STIMULANT AGENT; NOOTROPIC AGENT;

ALERTNESS; ANOREXIA; ATTENTION; COGNITION; DIZZINESS; DOSE RESPONSE; DROWSINESS; EXPERIMENTAL STUDY; HEADACHE; HUMAN; INFORMATION PROCESSING; INSOMNIA; LEARNING; MEMORY; PERFORMANCE; PRIORITY JOURNAL; PROBLEM SOLVING; PSYCHOSIS; REVIEW; SEIZURE; SINGLE DRUG DOSE; STOMACH PAIN; TACHYCARDIA; VISUAL LEARNING; VISUAL MEMORY; AGING; BRAIN; DRUG EFFECTS; NORMAL HUMAN; PHYSIOLOGY; PSYCHOLOGY;

AGING; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; HEALTHY VOLUNTEERS; HUMANS; METHYLPHENIDATE; NOOTROPIC AGENTS;

EID: 84899715169     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145713001594     Document Type: Review

References (102)

1. Agay N, Yechiam E, Carmel Z, Levkovitz Y. (2010) Non-specific effects of methylphenidate. (Ritalin) on cognitive ability and decision-making of ADHD and healthy adults. Psychopharmacology. (Berl) 210:511-519.
2. Aman MG, Vamos M, Werry JS. (1984) Effects of methylphenidate in normal adults with reference to drug action in hyperactivity. Aust N Z J Psychiatry 18:86-88.
3. Anderer P, Saletu B, Semlitsch HV, Pascual-Marqui RD. (2002) Perceptual and cognitive event-related potentials in neuropsychopharmacology: Methodological aspects and clinical applications. (pharmaco-ERP topography and tomography). Methods Find Exp Clin Pharmacol 24. (Suppl. C):121-137.
4. Baddeley A. (1992) Working memory. Science 255:556-559.
5. Ben-Itzhak R, Giladi N, Gruendlinger L, Hausdorff JM. (2008) Can methylphenidate reduce fall risk in community-living older adults? A double-blind, single-dose cross-over study. J Am Geriatr Soc 56:695-700.
6. Bernard K, Penelaud PF, Mocaer E, Donazzolo Y. (2011) Absence of psychostimulant effects of a supratherapeutic dose of tianeptine: A placebo-controlled study vs methylphenidate in young healthy volunteers. J Clin Psychopharmacol 31:441-448.
7. Bishop C, Roehrs T, Rosenthal L, Roth T. (1997) Alerting effects of methylphenidate under basal and sleep-deprived conditions. Exp Clin Psychopharmacol 5:344-352.
8. Brignell CM, Curran HV. (2006) Drugs, sweat, and fears: A comparison of the effects of diazepam and methylphenidate on fear conditioning. Psychopharmacol. (Berl) 186:504-516.
9. Brignell CM, Rosenthal J, Curran HV. (2007) Pharmacological manipulations of arousal and memory for emotional material: Effects of a single dose of methylphenidate or lorazepam. J Psychopharmacol 21:673-683.
10. Brumaghim JT, Klorman R. (1998) Methylphenidate's effects on paired-Associate learning and event-related potentials of young adults. Psychophysiol 35:73-85.
11. Brumaghim JT, Klorman R, Strauss J, Lewine JD, Goldstein MG. (1987) Does methylphenidate affect information processing? Findings from two studies on performance and P3b latency. Psychophysiol 24:361-373.
12. Bullmore E, Suckling J, Zelaya F, Long C, Honey G, Reed L, Routledge C, Ng V, Fletcher P, Brown J, Williams SC. (2003) Practice and difficulty evoke anatomically and pharmacologically dissociable brain activation dynamics. Cereb Cortex 13:144-154.
13. Callaway E. (1984) Human information-processing: Some effects of methylphenidate, age, and scopolamine. Biol Psychiatry 19:649-662.
14. Campbell-Meiklejohn D, Simonsen A, Scheel-Kruger J, Wohlert V, Gjerloff T, Frith CD, Rogers RD, Roepstorff A, Moller A. (2012) In for a penny, in for a pound: Methylphenidate reduces the inhibitory effect of high stakes on persistent risky choice. J Neurosci 32:13032-13038.
15. Camp-Bruno JA, Herting RL. (1994) Cognitive effects of milacemide and methylphenidate in healthy young adults. Psychopharmacol. (Berl) 115:46-52.
16. Clark CR, Geffen GM, Geffen LB. (1986) Role of monoamine pathways in the control of attention: Effects of droperidol and methylphenidate in normal adult humans. Psychopharmacolo. (Berl) 90:28-34.
17. Clark CR, Geffen GM, Geffen LB. (1986) Role of monoamine pathways in attention and effort: Effects of clonidine and methylphenidate in normal adult humans. Psychopharmacol. (Berl) 90:35-39.
18. Clatworthy PL, Lewis SJ, Brichard L, Hong YT, Izquierdo D, Clark L, Cools R, Aigbirhio FI, Baron JC, Fryer TD, Robbins TW. (2009) Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. J Neurosci 29:4690-4696.
19. Cools R, Robbins TW. (2004) Chemistry of the adaptive mind. Philos Transact A Math Phys Eng Sci 362:2871-2888.
20. Coons HW, Peloquin LJ, Klorman R, Bauer LO, Ryan RM, Perlmutter RA, Salzman LF. (1981) Effect of methylphenidate on young adult's vigilance and event-related potentials. Electroencephalogr Clin Neurophysiol 51:373-387.
21. Cooper NJ, Keage H, Hermens D, Williams LM, Debrota D, Clark CR, Gordon E. (2005) The dose-dependent effect of methylphenidate on performance, cognition and psychophysiology. J Integr Neurosci 4:123-144.
22. Costa A, Riedel M, Pogarell O, Menzel-Zelnitschek F, Schwarz M, Reiser M, Moller HJ, Rubia K, Meindl T, Ettinger U. (2013) Methylphenidate effects on neural activity during response inhibition in healthy humans. Cereb Cortex 23:1179-1189.
23. Dickinson D, Ragland JD, Calkins ME, Gold JM, Gur RC. (2006) A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis. Schizophr Res 85:20-29.
24. Diller LH. (1996) The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990s. Hastings Cent Rep 26:12-18.
25. Dodds C, Muller U, Manly T. (2008) Effects of psychostimulants on alertness and spatial bias in healthy participants. J Cogn Neurosci 21:529-537.
26. Dodds CM, Muller U, Clark L, van Loon A, Cools R, Robbins TW. (2008) Methylphenidate has differential effects on blood oxygenation level-dependent signal related to cognitive subprocesses of reversal learning. J Neurosci 28:5976-5982.
27. Drijgers RL, Verhey FR, Tissingh G, van Domburg PH, Aalten P, Leentjens AF. (2012) The role of the dopaminergic system in mood, motivation and cognition in Parkinson's disease: A double blind randomized placebo-controlled experimental challenge with pramipexole and methylphenidate. J Neurol Sci 320:121-126.
28. Elliott R, Sahakian BJ, Matthews K, Bannerjea A, Rimmer J, Robbins TW. (1997) Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacol. (Berl) 131:196-206.
29. Finke K, Dodds CM, Bublak P, Regenthal R, Baumann F, Manly T, Muller U. (2010) Effects of modafinil and methylphenidate on visual attention capacity: A TVA-based study. Psychopharmacol. (Berl) 210:317-329.
30. Fitzpatrick P, Klorman R, Brumaghim JT, Keefover RW. (1988) Effects of methylphenidate on stimulus evaluation and response processes: Evidence from performance and event-related potentials. Psychophysiol 25:292-304.
31. Genderson MR, Dickinson D, Diaz-Asper CM, Egan MF, Weinberger DR, Goldberg TE. (2007) Factor analysis of neurocognitive tests in a large sample of schizophrenic probands, their siblings, and healthy controls. Schizophr Res 94:231-239.
32. Greely H, Sahakian B, Harris J, Kessler RC, Gazzaniga M, Campbell P, Farah MJ. (2008) Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 456:702-705.
33. Halliday R, Callaway E, Naylor H, Gratzinger P, Prael R. (1986) The effects of stimulant drugs on information processing in elderly adults. J Gerontol 41:748-757.
34. Hannestad J, Gallezot JD, Planeta-Wilson B, Lin SF, Williams WA, van Dyck CH, Malison RT, Carson RE, Ding YS. (2010) Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo. Biol Psychiatry 68:854-860.
35. Hermens DF, Cooper NJ, Clark CR, Debrota D, Clarke SD, Williams LM. (2007) An integrative approach to determine the best behavioral and biological markers of methylphenidate. J Integr Neurosci 6:105-140.
36. Hester R, Nandam LS, O'Connell RG, Wagner J, Strudwick M, Nathan PJ, Mattingley JB, Bellgrove MA. (2012) Neurochemical enhancement of conscious error awareness. J Neurosci 32:2619-2627.
37. Hink RF, Fenton WH Jr., Tinklenberg JR, Pfefferbaum A, Kopell BS. (1978) Vigilance and human attention under conditions of methylphenidate and secobarbital intoxication: An assessment using brain potentials. Psychophysiol 15:116-125.
38. Husain M, Mehta MA. (2011) Cognitive enhancement by drugs in health and disease. Trends Cogn Sci 15:28-36.
39. Izquierdo I, Bevilaqua LR, Rossato JI, Lima RH, Medina JH, Cammarota M. (2008) Age-dependent and age-independent human memory persistence is enhanced by delayed posttraining methylphenidate administration. Proc Natl Acad Sci USA 105:19504-19507.
40. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. (1996) Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17:1-12.
41. James W. (1890) The principles of psychology. New York: Henry Holt.
42. Kleijnen J, Knipschild P, Riet ter G. (1991) Clinical trials of homeopathy. BMJ 302:316-323.
43. Klein-Schwartz W. (2002) Abuse and toxicity of methylphenidate. Curr Opin Pediatr 14:219-223.
44. Kollins SH, Rush CR, Pazzaglia PJ, Ali JA. (1998) Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate. Exp Clin Psychopharmacol 6:367-374.
45. Kratz O, Diruf MS, Studer P, Gierow W, Buchmann J, Moll GH, Heinrich H. (2009) Effects of methylphenidate on motor system excitability in a response inhibition task. Behav Brain Funct 5:12.
46. Kupietz SS, Richardson E, Gadow KD, Winsberg BG. (1980) Effects of methylphenidate on learning a 'beginning reading vocabulary' by normal adults. Psychopharmacol. (Berl) 69:69-72.
47. Kuypers KP, Ramaekers JG. (2005) Transient memory impairment after acute dose of 75 mg 3.4-Methylenedioxymethamphetamine. J Psychopharmacol 19:633-639.
48. Kuypers KP, Ramaekers JG. (2007) Acute dose of MDMA. (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected. Psychopharmacol. (Berl) 189:557-563.
49. Lakhan SE, Kirchgessner A. (2012) Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: Misuse, cognitive impact, and adverse effects. Brain Behav 2:661-677.
50. Larriviere D, Williams MA, Rizzo M, Bonnie RJ. (2009) Responding to requests from adult patients for neuroenhancements: Guidance of the Ethics, Law and Humanities Committee. Neurology 73:1406-1412.
51. Leonard BE, McCartan D, White J, King DJ. (2004) Methylphenidate: A review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol 19:151-180.
52. Linssen AM, Vuurman EF, Sambeth A, Nave S, Spooren W, Vargas G, Santarelli L, Riedel WJ. (2011) Contingent negative variation as a dopaminergic biomarker: Evidence from dose-related effects of methylphenidate. Psychopharmacol. (Berl) 218:533-542.
53. Linssen AM, Vuurman EF, Sambeth A, Riedel WJ. (2012) Methylphenidate produces selective enhancement of declarative memory consolidation in healthy volunteers. Psychopharmacol. (Berl) 221:611-619.
54. Lucke JC, Bell S, Partridge B, Hall WD. (2011) Deflating the neuroenhancement bubble. AJOB Neurosci 2:38-43.
55. Maher B. (2008) Poll results: Look who's doping. Nature 452:674-675.
56. Marquand AF, De Simoni S, O'Daly OG, Williams SC, Mourao-Miranda J, Mehta MA. (2011) Pattern classification of working memory networks reveals differential effects of methylphenidate, atomoxetine, and placebo in healthy volunteers. Neuropsychopharmacol 36:1237-1247.
57. Mehta MA, Riedel WJ. (2006) Dopaminergic enhancement of cognitive function. Curr Pharm Des 12:2487-2500.
58. Mehta MA, Calloway P, Sahakian BJ. (2000) Amelioration of specific working memory deficits by methylphenidate in a case of adult attention deficit/hyperactivity disorder. J Psychopharmacol 14:299-302.
59. Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW. (2000) Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 20:RC65.
60. Moeller SJ, Honorio J, Tomasi D, Parvaz MA, Woicik PA, Volkow ND, Goldstein RZ. (2012) Methylphenidate enhances executive function and optimizes prefrontal function in both health and cocaine addiction. Cereb Cortex Epub ahead of print.
61. Muller U, Suckling J, Zelaya F, Honey G, Faessel H, Williams SC, Routledge C, Brown J, Robbins TW, Bullmore ET. (2005) Plasma level-dependent effects of methylphenidate on task-related functional magnetic resonance imaging signal changes. Psychopharmacol. (Berl) 180:624-633.
62. Nandam LS, Hester R, Wagner J, Cummins TD, Garner K, Dean AJ, Kim BN, Nathan PJ, Mattingley JB, Bellgrove MA. (2011) Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability. Biol Psychiatry 69:902-904.
63. Naylor H, Halliday R, Callaway E. (1985) The effect of methylphenidate on information processing. Psychopharmacol. (Berl) 86:90-95.
64. Nieoullon A. (2002) Dopamine and the regulation of cognition and attention. Prog Neurobiol 67:53-83.
65. Nieoullon A, Coquerel A. (2003) Dopamine: A key regulator to adapt action, emotion, motivation and cognition. Curr Opin Neurol 16. (Suppl. 2):S3-S9.
66. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. (2004) Identification of separable cognitive factors in schizophrenia. Schizophr Res 72:29-39.
67. Oken BS, Kishiyama SS, Salinsky MC. (1995) Pharmacologically induced changes in arousal: Effects on behavioral and electrophysiologic measures of alertness and attention. Electroencephalogr Clin Neurophysiol 95:359-371.
68. Partridge BJ, Bell SK, Lucke JC, Yeates S, Hall WD. (2011) Smart drugs 'as common as coffee': Media hype about neuroenhancement. PloS ONE 6:e28416. doi:10.1371/journal.pone.0028416.
69. Pauls AM, O'Daly OG, Rubia K, Riedel WJ, Williams SC, Mehta MA. (2012) Methylphenidate effects on prefrontal functioning during attentional-capture and response inhibition. Biol Psychiatry 72:142-149.
70. Pietrzak RH, Mollica CM, Maruff P, Snyder PJ. (2006) Cognitive effects of immediate-release methylphenidate in children with attention-deficit/ hyperactivity disorder. Neurosci Biobehav Rev 30:1225-1245.
71. Ragan CI, Bard I, Singh I. (2013) What should we do about student use of cognitive enhancers? An analysis of current evidence. Neuropharmacol 64:588-595.
72. Ramasubbu R, Singh H, Zhu H, Dunn JF. (2012) Methylphenidate-mediated reduction in prefrontal hemodynamic responses to working memory task: A functional near-infrared spectroscopy study. Hum Psychopharmacol 27:615-621.
73. Repantis D, Schlattmann P, Laisney O, Heuser I. (2010) Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacol Res 62:187-206.
74. Riedel WJ, Mehta MA, Unema PJ. (2006) Human cognition assessment in drug research. Curr Pharm Des 12:2525-2539.
75. Roehrs T, Papineau K, Rosenthal L, Roth T. (1999) Sleepiness and the reinforcing and subjective effects of methylphenidate. Exp Clin Psychopharmacol 7:145-150.
76. Rogers RD, Blackshaw AJ, Middleton HC, Matthews K, Hawtin K, Crowley C, Hopwood A, Wallace C, Deakin JF, Sahakian BJ, Robbins TW. (1999) Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: Implications for the monoaminergic basis of impulsive behaviour. Psychopharmacol. (Berl) 146:482-491.
77. Rush CR, Kollins SH, Pazzaglia PJ. (1998) Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-Amphetamine-Trained humans. Exp Clin Psychopharmacol 6:32-44.
78. Rush CR, Essman WD, Simpson CA, Baker RW. (2001) Reinforcing and subject-rated effects of methylphenidate and d-Amphetamine in non-drug-Abusing humans. J Clin Psychopharmacol 21:273-286.
79. Sahakian B, Morein-Zamir S. (2007) Professor's little helper. Nature 450:1157-1159.
80. Schroeder SR, Mann-Koepke K, Gualtieri CT, Eckerman DA, Breese GR. (1987) Methylphenidate affects strategic choice behavior in normal adult humans. Pharmacol Biochem Behav 28:213-217.
81. Smith ME, Farah MJ. (2011) Are prescription stimulants 'smart pills'? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol Bull 137:717-741.
82. Soetens E, D'Hooge R, Hueting JE. (1993) Amphetamine enhances human-memory consolidation. Neurosci Lett 161:9-12.
83. Soetens E, Casaer S, D'Hooge R, Hueting JE. (1995) Effect of amphetamine on long-Term retention of verbal material. Psychopharmacol. (Berl) 119:155-162.
84. Sternberg S. (1966) High-speed scanning in human memory. Science 153:652-654.
85. Stix G. (2009) Turbocharging the brain. Scientific American Mind 301:46-49, 52-55.
86. Stoops WW, Lile JA, Fillmore MT, Glaser PE, Rush CR. (2005) Reinforcing effects of methylphenidate: Influence of dose and behavioral demands following drug administration. Psychopharmacol. (Berl) 177:349-355.
87. Strauss J, Lewis JL, Klorman R, Peloquin LJ, Perlmutter RA, Salzman LF. (1984) Effects of methylphenidate on young adults' performance and event-related potentials in a vigilance and a paired-Associates learning test. Psychophysiol 21:609-621.
88. Studer P, Wangler S, Diruf MS, Kratz O, Moll GH, Heinrich H. (2010) ERP effects of methylphenidate and working memory load in healthy adults during a serial visual working memory task. Neurosci Lett 482:172-176.
89. Swanson JM, Volkow ND. (2008) Increasing use of stimulants warns of potential abuse. Nature 453:586.
90. Theunissen EL, Elvira Jde L, van den Bergh D, Ramaekers JG. (2009) Comparing the stimulant effects of the H1-Antagonist fexofenadine with 2 psychostimulants, modafinil and methylphenidate. J Clin Psychopharmacol 29:439-443.
91. Tomasi D, Volkow ND, Wang GJ, Wang R, Telang F, Caparelli EC, Wong C, Jayne M, Fowler JS. (2011) Methylphenidate enhances brain activation and deactivation responses to visual attention and working memory tasks in healthy controls. Neuroimage 54:3101-3110.
92. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ. (2003) Relative lack of cognitive effects of methylphenidate in elderly male volunteers. Psychopharmacol. (Berl) 168:455-464.
93. Unrug A, Coenen A, van Luijtelaar G. (1997) Effects of the tranquillizer diazepam and the stimulant methylphenidate on alertness and memory. Neuropsychobiol 36:42-48.
94. Volkow ND, Swanson JM. (2003) Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. AJ Psychiatry 160:1909-1918.
95. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS, Dewey S, Ashby C, Liebermann J, Hitzemann R, et al. (1995) Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 52:456-463.
96. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, Hitzemann R, Pappas N. (1998) Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. AJ Psychiatry 155:1325-1331.
97. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Wong C, Hitzemann R, Pappas NR. (1999) Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors. J Pharmacol Exp Ther 291:409-415.
98. Volkow ND, Fowler JS, Wang GJ, Ding YS, Gatley SJ. (2002) Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: Results from imaging studies. Eur Neuropsychopharmacol 12:557-566.
99. Volkow ND, Fowler JS, Wang GJ, Telang F, Logan J, Wong C, Ma J, Pradhan K, Benveniste H, Swanson JM. (2008) Methylphenidate decreased the amount of glucose needed by the brain to perform a cognitive task. PLoS ONE 3:e2017. doi: 10.1371/journal.pone.0002017.
100. Wetzel CD, Squire LR, Janowsky DS. (1981) Methylphenidate impairs learning and memory in normal adults. Behav Neural Biol 31:413-424.
101. Zeeuws I, Soetens E. (2007) Verbal memory performance improved via an acute administration of D-Amphetamine. Hum Psychopharmacol 22:279-287.
102. Zhu Y, Gao B, Hua J, Liu W, Deng Y, Zhang L, Jiang B, Zang Y. (2013) Effects of methylphenidate on resting-state brain activity in normal adults: An fMRI study. Neurosci Bull 29:16-27.